WebApr 19, 2024 · Net trade sales were USD 953 million in the U.S. and USD 903 million in the rest of the world. Genmab receives royalties on the worldwide net sales of DARZALEX, both the intravenous and SC... WebAug 31, 2024 · Darzalex Faspro®, a combination of Darzalex and hyaluronidase (an endoglycosidase), is a formulation given as an abdominal injection under the skin (subcutaneous, SQ) to treat adult patients with multiple myeloma. It has been determined to be as effective as the original formulation of Darzalex.
Genmab Announces Net Sales of DARZALEX® …
WebFeb 14, 2024 · Darzalex Faspro (daratumumab/hyaluronidase-fihj) is a brand-name prescription medication. It’s approved by the Food and Drug Administration (FDA) to … WebDec 4, 2024 · about darzalex faspro ® /darzalex ® sc In August 2012 , Janssen Biotech, Inc. and Genmab A/S entered a worldwide agreement, which granted Janssen an exclusive license to develop, manufacture and ... pa staff untitled
HIGHLIGHTS OF PRESCRIBING INFORMATION
WebJul 19, 2024 · COPENHAGEN, Denmark; July 19, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX® (daratumumab), … WebOct 19, 2024 · Darzalex Faspro is a subcutaneous formulation of Darzalex, an established treatment for multiple myeloma that is given by intravenous infusion over a period of hours. Darzalex Faspro is administered by subcutaneous injection over a much shorter period of approximately three to five minutes. What is Darzalex Faspro used to treat? WebApr 19, 2024 · Net trade sales were USD 953 million in the U.S. and USD 903 million in the rest of the world. Genmab receives royalties on the worldwide net sales of DARZALEX, … pasta fetuccini